Benchmark Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | $1.97M | Sell |
37,900
-1,050
| -3% | -$54.6K | 1.96% | 13 |
|
2018
Q3 | $2.42M | Sell |
38,950
-600
| -2% | -$37.2K | 1.82% | 13 |
|
2018
Q2 | $2.19M | Sell |
39,550
-40,800
| -51% | -$2.26M | 1.66% | 15 |
|
2018
Q1 | $5.08M | Sell |
80,350
-5,650
| -7% | -$357K | 4.02% | 3 |
|
2017
Q4 | $5.27M | Sell |
86,000
-12,034
| -12% | -$737K | 4.11% | 2 |
|
2017
Q3 | $6.25M | Sell |
98,034
-1,100
| -1% | -$70.1K | 4.85% | 1 |
|
2017
Q2 | $5.52M | Buy |
99,134
+500
| +0.5% | +$27.9K | 4.36% | 2 |
|
2017
Q1 | $5.36M | Buy |
98,634
+8,400
| +9% | +$457K | 4.24% | 3 |
|
2016
Q4 | $5.27M | Buy |
90,234
+9,075
| +11% | +$530K | 4.37% | 2 |
|
2016
Q3 | $4.38M | Buy |
81,159
+20,125
| +33% | +$1.09M | 3.3% | 3 |
|
2016
Q2 | $4.49M | Buy |
61,034
+10,534
| +21% | +$775K | 3.66% | 3 |
|
2016
Q1 | $3.23M | Sell |
50,500
-300
| -0.6% | -$19.2K | 2.83% | 5 |
|
2015
Q4 | $3.5M | Sell |
50,800
-200
| -0.4% | -$13.8K | 2.96% | 5 |
|
2015
Q3 | $3.02M | Hold |
51,000
| – | – | 2.46% | 7 |
|
2015
Q2 | $3.39M | Hold |
51,000
| – | – | 2.39% | 7 |
|
2015
Q1 | $3.29M | Sell |
51,000
-300
| -0.6% | -$19.3K | 2.16% | 11 |
|
2014
Q4 | $3.03M | Hold |
51,300
| – | – | 2.04% | 12 |
|
2014
Q3 | $2.63M | Sell |
51,300
-500
| -1% | -$25.6K | 1.81% | 13 |
|
2014
Q2 | $2.51M | Sell |
51,800
-300
| -0.6% | -$14.6K | 1.57% | 18 |
|
2014
Q1 | $2.71M | Sell |
52,100
-400
| -0.8% | -$20.8K | 1.88% | 15 |
|
2013
Q4 | $2.79M | Sell |
52,500
-900
| -2% | -$47.8K | 1.93% | 12 |
|
2013
Q3 | $2.47M | Buy |
+53,400
| New | +$2.47M | 1.77% | 14 |
|